The inquiry has based its work on patient and consumer perspectives. In other words, it has designed a proposal to benefit these groups in terms of accessibility and price. The high level of expertise, security and quality that characterises the pharmaceutical trade today is to be maintained. The inquiry has conducted international comparisons of pharmacy markets and taken into consideration their strengths and weaknesses when drawing up the proposals. Another starting point was that the state is still to be responsible for supervising and monitoring the pharmaceuticals trade and pharmacy staff.